Suppr超能文献

原发性甲状旁腺功能亢进伴疑似异位甲状旁腺腺瘤患者的处理方法。

An Approach to a Patient With Primary Hyperparathyroidism and a Suspected Ectopic Parathyroid Adenoma.

机构信息

Department of Endocrinology, Wellcome-MRC Institute of Metabolic Science, University of Cambridge, and NIHR Cambridge Biomedical Research Centre, Cambridge University Hospitals, Cambridge, UK.

Department of Radiology, University of Cambridge, Cambridge, UK.

出版信息

J Clin Endocrinol Metab. 2022 May 17;107(6):1706-1713. doi: 10.1210/clinem/dgac024.

Abstract

Primary hyperparathyroidism (PHPT) is characterized by hypercalcemia driven by excess parathyroid hormone (PTH) secretion. PHPT is a common endocrine condition with a prevalence of 1 to 7 cases per 1000 adults. PHPT typically presents in the fifth or sixth decade and shows significant female preponderance. Solitary hyperfunctioning parathyroid adenomas account for 85% to 90% of PHPT cases. The remaining 10% to 15% include cases of multiglandular disease (multiple adenomas or hyperplasia) and, rarely, parathyroid carcinoma (1%). Ectopic parathyroid adenomas may arise due to abnormal embryological migration of the parathyroid glands and can be difficult to localize preoperatively, making surgical cure challenging on the first attempt. The potential existence of multiglandular disease should be considered in all patients in whom preoperative localization fails to identify a target adenoma or following unsuccessful parathyroidectomy. Risk factors for multiglandular disease include underlying genetic syndromes (eg, MEN1/2A), lithium therapy, or previous radiotherapy. In addition to multifocal disease, the possibility of an ectopic parathyroid gland should also be considered in patients requiring repeat parathyroid surgery. In this article, we use illustrative clinical vignettes to discuss the approach to a patient with primary hyperparathyroidism (PHPT) and a suspected ectopic parathyroid adenoma.

摘要

原发性甲状旁腺功能亢进症(PHPT)的特征是甲状旁腺激素(PTH)分泌过多导致的高钙血症。PHPT 是一种常见的内分泌疾病,每 1000 名成年人中就有 1 至 7 例。PHPT 通常发生在五、六十岁,女性发病率明显高于男性。甲状旁腺腺瘤的单一功能亢进占 PHPT 病例的 85%至 90%。其余 10%至 15%包括多腺体疾病(多个腺瘤或增生)和罕见的甲状旁腺癌(1%)。甲状旁腺腺瘤的异位可能是由于甲状旁腺的胚胎发育异常迁移引起的,并且在术前难以定位,使得首次手术治愈具有挑战性。在术前定位未能识别目标腺瘤或甲状旁腺切除术后不成功的所有患者中,都应考虑存在多腺体疾病的可能性。多腺体疾病的危险因素包括潜在的遗传综合征(例如 MEN1/2A)、锂治疗或先前的放射治疗。除了多灶性疾病外,对于需要重复甲状旁腺手术的患者,也应考虑异位甲状旁腺的可能性。在本文中,我们使用说明性临床病例来讨论原发性甲状旁腺功能亢进症(PHPT)伴疑似异位甲状旁腺腺瘤患者的处理方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验